Shionogi Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHIONOGI, and what generic alternatives to SHIONOGI drugs are available?
SHIONOGI has eight approved drugs.
There are four US patents protecting SHIONOGI drugs.
There are seventy-two patent family members on SHIONOGI drugs in thirty-eight countries and thirty-three supplementary protection certificates in sixteen countries.
Drugs and US Patents for Shionogi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shionogi | UROBAK | sulfamethoxazole | TABLET;ORAL | 087307-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | 10,004,750 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | 9,949,982 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Shionogi Inc | RYBIX ODT | tramadol hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021693-001 | May 5, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-003 | Sep 9, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-002 | Sep 9, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Shionogi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Shionogi Inc | DORIBAX | doripenem | INJECTABLE;INTRAVENOUS | 022106-002 | Oct 5, 2010 | 5,317,016 | ⤷ Try a Trial |
Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-004 | Sep 9, 1993 | 4,631,286 | ⤷ Try a Trial |
Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-002 | Sep 9, 1993 | 4,631,286 | ⤷ Try a Trial |
Shionogi Inc | ULESFIA | benzyl alcohol | LOTION;TOPICAL | 022129-001 | Apr 9, 2009 | 6,793,931 | ⤷ Try a Trial |
Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-002 | Sep 9, 1993 | 4,816,456 | ⤷ Try a Trial |
Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-001 | Sep 9, 1993 | 4,631,286 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SHIONOGI drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Lotion | 5% | ➤ Subscribe | 2016-04-11 |
➤ Subscribe | Injection | 250 mg/vial and 500 mg/vial | ➤ Subscribe | 2011-10-11 |
International Patents for Shionogi Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Israel | 211720 | ⤷ Try a Trial |
Denmark | 2960244 | ⤷ Try a Trial |
Lithuania | 2960244 | ⤷ Try a Trial |
Philippines | 12017500435 | ⤷ Try a Trial |
European Patent Office | 3189841 | ⤷ Try a Trial |
Eurasian Patent Organization | 019520 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Shionogi Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2960244 | 2090041-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROKOL; REG. NO/DATE: EU/1/20/1434 20200424 |
0503785 | C300133 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: OLMESARTAN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT VAN DE CARBOXYGROEP GEKOZEN UIT DE VOLGENDE : EEN ALKYLGROEP 1-4 KOOLSTOFATOMEN, EEN BENZYLGROEP, EEN ALKANOYLOXYALKYLGROEP WAARIN HET ALKANOYLDEEL 1-5; NATL. REGISTRATION NO/DATE: RVG 28785-RVG 28787 20030527; FIRST REGISTRATION: DE 502.02.00.00,502.02.01.00, 502.02.02.00 20020813 |
1307486 | 12C0041 | France | ⤷ Try a Trial | PRODUCT NAME: CYCLO((4R)-4(2-AMINOETHYLCARBAMOYLOXY)-L-PROLYL-L-PHENYLGLYCYL-D-TRYPTOPHYL-L-LYSYL-4-O-BENZYL-L-TYROSYL-L-PHENYLALANYL-) : PASIREOTIDE, OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/12/753/001 20120424 |
2960244 | 122020000060 | Germany | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROCOL; REGISTRATION NO/DATE: EU/1/20/1434 20200423 |
1506193 | SPC/GB14/044 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: RIOCIGUAT, I.E. METHYL N-(4,6-DIAMINO-2-(1-(2-FLUOROBENZYL)-1H-PYRAZOLO (3,4-B)PYRIDIN-3-YL)-5-PYRIMIDINYL(METHYL)CARBAMATE,OR A PHARMACEUTICALLY ACCEPTABLE SALT OR HYDRATE THEREOF.; REGISTERED: UK EU/1/13/907 20140331 |
1425001 | SPC/GB14/034 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: VILANTEROL OR SALTS OR SOLVATES THEREOF (I.E., 4-((1R)-2-((6-(2-((2,6-DICHLOROBENZYL)OXY)ETHOXY)HEXYL)AMINO)-1-HYDROXYETHYL)-2-(HYDROXYMETHYL)PHENOL OR SALTS OR SOLVATES THEREOF); REGISTERED: UK EU/1/13/886/001 20131114; UK EU/1/13/886/002 20131114; UK EU/1/13/886/003 20131114; UK EU/1/13/886/004 20131114; UK EU/1/13/886/005 20131114; UK EU/1/13/886/006 20131114 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.